Healthcare -
Biotechnology - NASDAQ - US
$ 7.48
2.89 %
$ 511 M
Market Cap
-3.76
P/E
EYPT - TOTAL CURRENT ASSETS
Total Current Assets EYPT - EyePoint Pharmaceuticals, Inc.
345 M
LAST VALUE
20.43%
2 YEAR CAGR
53.92%
5 YEAR CAGR
39.38%
10 YEAR CAGR